Make more informed decisions from factual data, enriched with the sentiment and opinion of patients, clinicians, payers & investors.

The challenge: Evaluating assets and companies requires significant internal capability and external consulting can slow you down when you need to make decisions quickly.

The solution: Our technology driven approach draws upon our full range of tools to provide you with the evidence you need to make your decision and reach a valuation, faster than your competition.

Deliverables.

• Clinical and competitive landscape assessments
• Epidemiology across your target markets
• Physician, patient and investor perspectives on disease, technology, product and company  
• We can address specific questions such as safety concerns and competing technologies
• Prioritisation of indications  
• Pricing assumptions for orphan or new assets in an established market

‍